drugset
drugset / Trial / NCT00498654

Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects

NCT00498654 ↗

Phase 2 Completed 180 enrolled Avant Immunotherapeutics
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this trial is to examine the safety and immunogenicity of Ty800 oral vaccine in healthy adult subjects.

Timeline

Start
2007-07
Primary completion
2007-10
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ty800 Vaccine — Oral

Indications

typhoid fever